AusculSciences Responds to COVID-19 Crisis
Due to the COVID-19 pandemic, recruitment of cardiac patients for participation in the CAD-det Study has been temporarily delayed. The company plans to bring the CAD-det System to market once clinical research can be completed safely at the University of Ottawa Heart Institute, the University of New Brunswick, and the University of Calgary.
The company has been in discussion with several medical institutions and government officials from both Canada and the USA regarding the possibility of re-purposing our expertise in bio-acoustic signal capture and analysis to address the current COVID-19 crisis. Research and development of a medical device to enhance patient and healthcare provider safety during the pandemic is currently being prototyped. Further details will be announced in the coming weeks.